STC-1010
Asset
Engages dendritic cells in vivo to activate antitumor T-cell responses.
- Stage
- Phase 1
- Modality
- Vaccine
- Target
- Not known
- 1
- Indication
- 0
- Trials
- 1
- Developer
Indications
1Microsatellite stable metastatic colorectal cancer
Phase 1, businesswire.com, Oct 23, 2026
In the full profile
- Owner and partners1
Every asset’s record: target, stage, trials and the evidence behind it.